⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
High antipsychotic prescribing (65+)
Risk indicators are statistical patterns, not allegations. Learn more
18,218
Total Claims
$4.8M
Drug Cost
1,555
Beneficiaries
$3,099
Cost/Patient
Risk Score Breakdown 12/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
-40%
Cost per patient vs peers
$3,099 vs $5,138 avg
-51%
Brand preference vs peers
29.9% vs 61.4% avg
Brand vs Generic
70% generic
Brand: 5,362 claims · $3.9M
Generic: 12,590 claims · $957K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 26 | $438K |
| Fluticasone/Umeclidin/Vilanter | 493 | $390K |
| Budesonide/Formoterol Fumarate | 421 | $207K |
| Budesonide | 46 | $198K |
| Chlorpromazine Hcl | 171 | $192K |
| Fluticasone/Vilanterol | 401 | $190K |
| Cyclosporine | 115 | $179K |
| Semaglutide | 89 | $153K |
| Icosapent Ethyl | 179 | $129K |
| Sitagliptin Phosphate | 112 | $122K |
| Umeclidinium Bromide | 275 | $120K |
| Linaclotide | 120 | $119K |
| Fluticasone Propion/Salmeterol | 231 | $119K |
| Empagliflozin | 94 | $109K |
| Dulaglutide | 57 | $95K |
Prescribing Profile
Patient Profile
73
Avg Age
57%
Female
1.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About